Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model.

Kitaori T, Ito H, Schwarz EM, Tsutsumi R, Yoshitomi H, Oishi S, Nakano M, Fujii N, Nagasawa T, Nakamura T.

Arthritis Rheum. 2009 Mar;60(3):813-23. doi: 10.1002/art.24330.

4.

Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.

Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A, Ratajczak J, Ratajczak MZ.

Stem Cells. 2005 Aug;23(7):879-94. Epub 2005 May 11. Review.

5.

Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer.

Dewan MZ, Ahmed S, Iwasaki Y, Ohba K, Toi M, Yamamoto N.

Biomed Pharmacother. 2006 Jul;60(6):273-6. Epub 2006 Jun 28. Review.

PMID:
16828253
6.

The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases?

Hirbe AC, Morgan EA, Weilbaecher KN.

Curr Pharm Des. 2010;16(11):1284-90. Review.

PMID:
20166978
7.

Stromal derived growth factor-1alpha as a beacon for stem cell homing in development and injury.

Claps CM, Corcoran KE, Cho KJ, Rameshwar P.

Curr Neurovasc Res. 2005 Oct;2(4):319-29. Review.

PMID:
16181123
8.

Homing genes, cell therapy and stroke.

Shyu WC, Lee YJ, Liu DD, Lin SZ, Li H.

Front Biosci. 2006 Jan 1;11:899-907. Review.

PMID:
16146779
9.

Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy.

Zaruba MM, Franz WM.

Expert Opin Biol Ther. 2010 Mar;10(3):321-35. doi: 10.1517/14712590903460286. Review.

PMID:
20132055
10.

Platelets and stromal cell-derived factor-1 in progenitor cell recruitment.

Stellos K, Gawaz M.

Semin Thromb Hemost. 2007 Mar;33(2):159-64. Review.

PMID:
17340464
11.

Modulation of the SDF-1-CXCR4 axis by the third complement component (C3)--implications for trafficking of CXCR4+ stem cells.

Ratajczak MZ, Reca R, Wysoczynski M, Yan J, Ratajczak J.

Exp Hematol. 2006 Aug;34(8):986-95. Review.

PMID:
16863905
12.
13.

SDF-1α as a therapeutic stem cell homing factor in myocardial infarction.

Ghadge SK, Mühlstedt S, Ozcelik C, Bader M.

Pharmacol Ther. 2011 Jan;129(1):97-108. doi: 10.1016/j.pharmthera.2010.09.011. Epub 2010 Oct 20. Review.

PMID:
20965212
15.

Concise review: the potential of stromal cell-derived factor 1 and its receptors to promote stem cell functions in spinal cord repair.

Jaerve A, Schira J, Müller HW.

Stem Cells Transl Med. 2012 Oct;1(10):732-9. doi: 10.5966/sctm.2012-0068. Epub 2012 Oct 10. Review.

16.

CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment.

Burger JA, Kipps TJ.

Blood. 2006 Mar 1;107(5):1761-7. Epub 2005 Nov 3. Review.

17.
18.

Chemokines in hematopoiesis.

Broxmeyer HE.

Curr Opin Hematol. 2008 Jan;15(1):49-58. Review.

PMID:
18043246
19.

CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization.

Liekens S, Schols D, Hatse S.

Curr Pharm Des. 2010;16(35):3903-20. Review.

PMID:
21158728
20.

Regenerative therapy for stroke.

Chang YC, Shyu WC, Lin SZ, Li H.

Cell Transplant. 2007;16(2):171-81. Review.

PMID:
17474298

Supplemental Content

Support Center